Task Force to Study Access to Mental Health Care in Higher Education
Sponsor: Delegate Valentino-SmithCommittee: AppropriationsSubject: Higher EducationStatus: Hearing 1/20 at 1:30 p.m. (as of Dec 1, 2021)
What this bill does
Official synopsis
Establishing the Task Force to Study Access to Mental Health Care in Higher Education; requiring the Task Force to study and make recommendations regarding barriers to providing mental health services on campus, the use of telemedicine, video conferencing and hotlines, and implementation of counseling services; requiring the Task Force to submit an interim report on or before December 1, 2021, and a final report on or before December 1, 2022, to certain committees of the General Assembly; etc.
AI analysis is off. Set ANTHROPIC_API_KEY to enable summaries, pros and cons, and questions.
Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.
Testimony (23)
MGA witness listFAV 18FavorableFWA 3Favorable with amendmentsINFO 2Information only
Organizations on record
Johns HopkinsFAV 1
Kaiser PermanenteFAV 1
Registered lobbyists who testified
FAVCyphers, MoiraCompass Government RelationsRegistered for: American Clean Power; American Clean Power Association (ACP)
FAVJordan, Lisae CMaryland Coalition Against Sexual Assault (MCASA)Registered for: Maryland Coalition Against Sexual Assault
FAVQuinlan, MargoMental Health Association of MarylandRegistered for: Mental Health Association of Maryland
FWABrocato, BarbaraRegistered for: Acorn Health; American Physical Therapy Association Maryland - APTA MD; Arthritis & Rheumatism Associates, P.C.; Associates in Radiation Medicine; League for People with Disabilities, The; Maryland Academy of Nutrition and Dietetics…
INFOPaddy, MichaelMaryland Insurance AdministrationRegistered for: American Cancer Society Cancer Action Network; Campaign to Protect Patient Health d/b/a Value of Care Coalition; Chase Brexton Health System; Diabetes Patient Advocacy Coalition; Gaudenzia, Inc.; Gilead Sciences, Inc.…
